Tyrosine

ret proto-oncogene ; Mus musculus







27 Article(s)
Download
PMID
Title
Pub. Year
#Total Relationships
1 35095393 Multiple Molecular Pathways Are Influenced by Progranulin in a Neuronal Cell Model-A Parallel Omics Approach. 2021 1
2 21612845 Partial impairment of c-Ret at tyrosine 1062 accelerates age-related hearing loss in mice. 2012 Mar 4
3 22295143 c-Ret-mediated hearing losses. 2012 1
4 22627285 Novel mechanisms of early upper and lower urinary tract patterning regulated by RetY1015 docking tyrosine in mice. 2012 Jul 2
5 21070764 Loss of Sprouty2 partially rescues renal hypoplasia and stomach hypoganglionosis but not intestinal aganglionosis in Ret Y1062F mutant mice. 2011 Jan 15 1
6 21283077 Differential expression of c-Ret in motor neurons versus non-neuronal cells is linked to the pathogenesis of ALS. 2011 Mar 3
7 20616061 c-Ret-mediated hearing loss in mice with Hirschsprung disease. 2010 Jul 20 2
8 19056869 Loss of Sprouty1 rescues renal agenesis caused by Ret mutation. 2009 Feb 3
9 17962702 Gdnf upregulates c-Fos transcription via the Ras/Erk1/2 pathway to promote mouse spermatogonial stem cell proliferation. 2008 Jan 1
10 18363967 GDNF-mediated signaling via RET tyrosine 1062 is essential for maintenance of spermatogonial stem cells. 2008 Apr 3
11 18497757 Analysis of Ret knockin mice reveals a critical role for IKKs, but not PI 3-K, in neurotrophic factor-induced survival of sympathetic neurons. 2008 Sep 1
12 16452504 Critical and distinct roles for key RET tyrosine docking sites in renal development. 2006 Feb 1 2
13 16227613 Phosphotyrosine 1062 is critical for the in vivo activity of the Ret9 receptor tyrosine kinase isoform. 2005 Nov 3
14 15240784 Cellular effects and antitumor activity of RET inhibitor RPI-1 on MEN2A-associated medullary thyroid carcinoma. 2004 Jul 7 1
15 15286081 Dok-6, a Novel p62 Dok family member, promotes Ret-mediated neurite outgrowth. 2004 Oct 1 4
16 15340065 A targeting mutation of tyrosine 1062 in Ret causes a marked decrease of enteric neurons and renal hypoplasia. 2004 Sep 2
17 12527893 Ras-mediated apoptosis of PC CL 3 rat thyroid cells induced by RET/PTC oncogenes. 2003 Jan 16 2
18 12637586 Activation of signal transducer and activator of transcription 3 by oncogenic RET/PTC (rearranged in transformation/papillary thyroid carcinoma) tyrosine kinase: roles in specific gene regulation and cellular transformation. 2003 Jun 4
19 12917638 Grap-2, a novel RET binding protein, is involved in RET mitogenic signaling. 2003 Aug 14 1
20 11956105 Repair by Src kinase of function-impaired RET with multiple endocrine neoplasia type 2A mutation with substitutions of tyrosines in the COOH-terminal kinase domain for phenylalanine. 2002 Apr 15 2
21 12444552 The roles of phosphotyrosines-294, -404, and -451 in RET/PTC1-induced thyroid tumor formation. 2002 Nov 21 1
22 10652431 Inhibition of transforming activity of the ret/ptc1 oncoprotein by a 2-indolinone derivative. 2000 Feb 1 2
23 8628282 The full oncogenic activity of Ret/ptc2 depends on tyrosine 539, a docking site for phospholipase Cgamma. 1996 May 2
24 7559572 Tyrosines outside the kinase core and dimerization are required for the mitogenic activity of RET/ptc2. 1995 Oct 20 2
25 7916147 The high transforming potency of erbB-2 and ret is associated with phosphorylation of paxillin and a 23 kDa protein. 1994 Oct 1
26 1630812 Establishment and characterization of a malignant melanocytic tumor cell line expressing the ret oncogene. 1992 Aug 4
27 1958211 The ret oncogene products are membrane-bound glycoproteins phosphorylated on tyrosine residues in vivo. 1991 Nov 27 2